Menu
Back to User profile » Dr Martin Hale
Papers published by Dr Martin Hale:
Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies
Chey WD, Brenner DM, Cash BD, Hale M, Adler J, Jamindar MS, Rockett CB, Almenoff JS, Bortey E, Gudin J
Journal of Pain Research 2023, 16:2943-2953
Published Date: 28 August 2023
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies
Camilleri M, Hale M, Morlion B, Tack J, Webster L, Wild J
Journal of Pain Research 2021, 14:2179-2189
Published Date: 16 July 2021
Benefit-Risk Analysis of Buprenorphine for Pain Management
Hale M, Garofoli M, Raffa RB
Journal of Pain Research 2021, 14:1359-1369
Published Date: 24 May 2021
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy
Webster LR, Hale ME, Yamada T, Wild JE
Journal of Pain Research 2020, 13:605-612
Published Date: 24 March 2020
Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids
Hale M, Urdaneta V, Kirby MT, Xiang Q, Rauck R
Journal of Pain Research 2017, 10:233-240
Published Date: 25 January 2017
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
Hale ME, Laudadio C, Yang R, Narayana A, Malamut R
Journal of Pain Research 2015, 8:623-636
Published Date: 15 September 2015
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
Nalamachu S, Rauck RL, Hale ME, Florete Jr OG, Robinson CY, Farr SJ
Journal of Pain Research 2014, 7:669-678
Published Date: 21 November 2014
Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain
Hale ME, Nalamachu SR, Khan A, Kutch M
Journal of Pain Research 2013, 6:319-329
Published Date: 1 May 2013